Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Meignan

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 29, 2017
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphomaAlberto Biggi, Fabrizio Bergesio, Stephane Chauvie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2007
Image of the month. Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CTGaetano Paone, Emmanuel Itti, Daniela Capacchione, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2020
Deep-Learning <sup>18</sup>F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell LymphomaNicolò Capobianco, Michel Meignan, Anne-Ségolène Cottereau, et al.
Nuclear Medicine Communications|June 2, 2017
Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial reviewJulien Dubreuil, Gilles Salles, Juliette Bozzetto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysisChieh Lin, Emmanuel Itti, Corinne Haioun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2012
Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomographyJean-Daniel Lelièvre, Giovanna Melica, Emmanuel Itti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2022
<sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL PatientsKibrom B Girum, Louis Rebaud, Anne-Ségolène Cottereau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2013
International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewersAlberto Biggi, Andrea Gallamini, Stephane Chauvie, et al.
The Lancet. Oncology|April 4, 2019
PET-guided, BEACOPP<sub>escalated</sub> therapy in advanced Hodgkin lymphoma - Authors' replyRené-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Blood|April 30, 2005
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcomeCorinne Haioun, Emmanuel Itti, Alain Rahmouni, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 29, 2017
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphomaAlberto Biggi, Fabrizio Bergesio, Stephane Chauvie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2007
Image of the month. Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CTGaetano Paone, Emmanuel Itti, Daniela Capacchione, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2020
Deep-Learning <sup>18</sup>F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell LymphomaNicolò Capobianco, Michel Meignan, Anne-Ségolène Cottereau, et al.
Nuclear Medicine Communications|June 2, 2017
Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial reviewJulien Dubreuil, Gilles Salles, Juliette Bozzetto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysisChieh Lin, Emmanuel Itti, Corinne Haioun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2012
Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomographyJean-Daniel Lelièvre, Giovanna Melica, Emmanuel Itti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2022
<sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL PatientsKibrom B Girum, Louis Rebaud, Anne-Ségolène Cottereau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2013
International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewersAlberto Biggi, Andrea Gallamini, Stephane Chauvie, et al.
The Lancet. Oncology|April 4, 2019
PET-guided, BEACOPP<sub>escalated</sub> therapy in advanced Hodgkin lymphoma - Authors' replyRené-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Blood|April 30, 2005
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcomeCorinne Haioun, Emmanuel Itti, Alain Rahmouni, et al.
Pageof 13